N. Gardiner

Monitoring of lineage-specific chimaerism allows early prediction of response following donor lymphocyte infusions for relapsed chronic myeloid leukaemia

N. Gardiner, Mark Lawler, JM O’Riordan et al. · Bone Marrow Transplantation · 1998 · 54 citations

Mixed-phenotype Acute Leukemia, Immunology, Myeloid Neoplasia +16

A single-centre assessment of long-term quality-of-life status after sibling allogeneic stem cell transplantation for chronic myeloid leukaemia in first chronic phase

Patrick Hayden, Fiona Keogh, Mairead Ni Conghaile et al. · Bone Marrow Transplantation · 2004 · 43 citations

Hematological Malignancy, Family Medicine, Quality Of Life +11

Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia

N. Gardiner, Mark Lawler, J O’Riordan et al. · Bone Marrow Transplantation · 1997 · 39 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +13

High frequency of donor chimerism after allogeneic transplantation of CD34+-selected peripheral blood cells.

Javier Briones, Álvaro Urbano-Ispizúa, Mark Lawler et al. · PubMed · 1998 · 31 citations

Donor chimaerism is a strong indicator of disease free survival following bone marrow transplantation for chronic myeloid leukaemia.

N. Gardiner, Mark Lawler, J O’Riordan et al. · PubMed · 1997 · 16 citations